ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

OKYO OKYO Pharma Ltd

1,4242
-0,0658 (-4,42%)
07 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
OKYO Pharma Ltd OKYO NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,0658 -4,42% 1,4242 18:00:01
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
1,41 1,41 1,47 1,4242 1,49
mais cotações »

Notícias Recentes

Data Hora Fonte Título
30/04/202408:00GLOBEOKYO Pharma Announces Upcoming Presentation of OK-101 Phase..
08/04/202420:00GLOBEOKYO Pharma to Reschedule Key Opinion Leader Event in Dry..
02/04/202408:00GLOBEOKYO Pharma Announces Upcoming Presentation of OK-101 Phase..
22/03/202408:00GLOBEOKYO Pharma Announces OK-101 Successfully Achieved..
21/03/202408:00GLOBEOKYO Pharma to Host Key Opinion Leader Event to Discuss New..
20/03/202408:00GLOBEOKYO Pharma to Release New and Comprehensive Data from Phase..
09/02/202409:36IHNWOKYO Pharma Receives FDA Approval of IND for OK-101 in..
09/02/202409:00GLOBEOKYO Pharma Receives FDA Approval of IND for OK-101 in..
31/01/202409:00GLOBEOKYO Pharma Announces Distinguished Ophthalmologists with..
08/01/202409:00GLOBEOKYO Pharma Announces OK-101 Successfully Achieved..
05/01/202411:30GLOBEOKYO Pharma to Present at the Biotech Showcase Conference in..
04/12/202309:00GLOBEOKYO Pharma Announces Last Patient Enrolled in OK-101 Phase..
31/10/202308:00GLOBEOKYO Pharma Announces $5.84 Million Cash Raise and Payables..
09/10/202312:34IHNWOKYO Pharma Announces Filing of an Investigational New Drug..
09/10/202308:00GLOBEOKYO Pharma Announces Filing of an Investigational New Drug..
05/10/202308:00GLOBEOKYO Pharma Announces Positive Safety Data Profile for the..
15/09/202308:00GLOBEOKYO Pharma Announces Closing of $4.0 Million Registered..
14/09/202310:15GLOBEOKYO Pharma Announces Pricing of $4.0 Million Registered..
14/09/202309:45GLOBEOKYO Pharma Limited Announces Withdrawal of Public Offering
13/09/202317:05GLOBEOKYO Pharma Announces Public Offering of Ordinary Shares
08/09/202308:04IHNWOKYO Pharma Completes Enrollment in Phase 2 Clinical Trial..
08/09/202308:00GLOBEOKYO Pharma Completes Enrollment in Phase 2 Clinical Trial..
30/08/202308:00GLOBEOKYO Pharma Achieves 90% Enrollment in 240-Patient Phase 2..
29/08/202308:00GLOBEOKYO Pharma Limited Regains Compliance with Nasdaq Listing..
15/08/202310:00GLOBEOKYO Pharma Limited Reports Annual Results for the Twelve..
31/07/202303:18GLOBEOKYO Pharma Limited Announces Withdrawal of Public Offering
28/07/202318:25GLOBEOKYO Pharma Announces Proposed Public Offering of Ordinary..
28/07/202318:05GLOBEOKYO Pharma Limited Receives Nasdaq Deficiency Notice
28/07/202308:01GLOBEOKYO Pharma Plans to Initiate Phase 2 Trial of OK-101 in..
27/07/202312:30GLOBEOKYO Pharma Announces Appointment of William A. Clementi as..
06/06/202310:30GLOBEOKYO Pharma Announces Randomized Segment Now Underway in..
11/05/202308:00GLOBEOKYO Pharma Now Participating on the Webull Corporate..

Seu Histórico Recente

Delayed Upgrade Clock